© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
April 12, 2013
Over 10 years, lifestyle intervention and metformin were cost-effective or cost saving compared with placebo.
Eyes with nAMD Treated with Ranibizumab Maintained Visual Acuity at SRF Resolution
Dietary Eliminations May Not Significantly Benefit Pediatric Eczema
Antibiotics to Treat Upper Respiratory Infections Increase Risk of C Difficile Infections